Goldman Sachs Group »

Reneo Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $104k 65k 1.60
2023-09-30 $322k 42k 7.62

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Highbridge Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
BML Capital Management
Ikarian Capital
BlackRock
Vanguard Group
Aisling Capital Management
Caption Management
Acuitas Investments
Geode Capital Management
Two Sigma Investments

View all funds holding Reneo Pharmaceuticals